- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Helliwell, S. B.
- Articles by Hall, M. N.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Helliwell, S. B.
- Articles by Hall, M. N.
TOR2 Is Part of Two Related Signaling Pathways Coordinating Cell Growth in Saccharomyces cerevisiae
Stephen B. Helliwell1,a, Isabelle Howalda, Nik Barbeta, and Michael N. Hallaa Department of Biochemistry, Biozentrum, University of Basel, CH-4056 Basel, Switzerland
Corresponding author: Michael N. Hall, Department of Biochemistry, Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland, hall{at}ubaclu.unibas.ch (E-mail).
Communicating editor: A. G. HINNEBUSCH
| ABSTRACT |
|---|
The Saccharomyces cerevisiae genes TOR1 and TOR2 encode phosphatidylinositol kinase homologs. TOR2 has two essential functions. One function overlaps with TOR1 and mediates protein synthesis and cell cycle progression. The second essential function of TOR2 is unique to TOR2 and mediates the cell-cycle-dependent organization of the actin cytoskeleton. We have isolated temperature-sensitive mutants that are defective for either one or both of the two TOR2 functions. The three classes of mutants were as follows. Class A mutants, lacking only the TOR2-unique function, are defective in actin cytoskeleton organization and arrest within two to three generations as small-budded cells in the G2/M phase of the cell cycle. Class B mutants, lacking only the TOR-shared function, and class C mutants, lacking both functions, exhibit a rapid loss of protein synthesis and a G1 arrest within one generation. To define further the two functions of TOR2, we isolated multicopy suppressors that rescue the class A or B mutants. Overexpression of MSS4, PKC1, PLC1, RHO2, ROM2, or SUR1 suppressed the growth defect of a class A mutant. Surprisingly, overexpression of PLC1 and MSS4 also suppressed the growth defect of a class B mutant. These genes encode proteins that are involved in phosphoinositide metabolism and signaling. Thus, the two functions (readouts) of TOR2 appear to involve two related signaling pathways controlling cell growth.
TOR1 and TOR2 are phosphatidylinositol (PI) kinase homologs originally identified genetically by dominant mutations that conferred rapamycin resistance in Saccharomyces cerevisiae (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
TOR2 has two functions. In contrast to cells lacking TOR1 and TOR2, cells lacking only TOR2 do not display a G0 arrest phenotype, but instead undergo a few cell divisions before arresting randomly in the cell cycle (![]()
![]()
![]()
![]()
![]()
![]()
Here we describe the isolation and characterization of different classes of TOR mutants that indicate that TOR2 indeed has two functions (or readouts). Suppressor analyses of representative mutants of these phenotypic classes suggest that the TOR2 functions are carried out by related signaling pathways.
| MATERIALS AND METHODS |
|---|
Strains, plasmids, and media:
The yeast strains used in this study are described in Table 1. Escherischia coli strain MH4 is
(lac)X74 hsr- hsm+ strA leuB600 galE galK. Plasmid pJK4 (YCplac111::TOR2) (![]()
![]()
![]()
![]()
![]()
|
Hydroxylamine mutagenesis, plasmid shuffling, and screening for tor2 ts mutants:
Mutagenesis was performed on YCplac111::TOR2 (CEN LEU2) (pJK4) plasmid DNA as described (![]()
Plasmids bearing each of the ts alleles were transformed into JK9-3da (TOR1 TOR2) and NB17-3d (tor1 TOR2) to determine whether these alleles were recessive to the genomic copy of TOR2. As expected, none of the plasmid-borne alleles exhibited any dominant effects in JK9-3da (TOR1 TOR2) as judged by a normal growth rate of transformants at 37° on solid minimal medium lacking leucine. However, the alleles tor2-21 ts and tor2-156 ts caused a reduction in growth rate at 37° when expressd in NB17-3d (tor1 TOR2), and additionally, the plasmid-borne tor2-156ts slightly inhibited the growth of NB17-3d (tor1 TOR2) at 24° (data not shown). This suggests that in the absence of the genomic copy of TOR1, these CEN plasmid-based mutant alleles can have a dominant effect over the single genomic copy of TOR2.
Growth curves and FACS analysis:
Cultures were grown to log phase at 24° in SD medium, then diluted to give an OD600 of approximately 0.05 in prewarmed media, and shaken at 37°. The OD600 was then determined at the times indicated. To easily assess the number of generations each strain went through, we divided all the resultant OD readings by the OD600 at the time of shift for any particular strain. Samples for fluorescence-activated cell sorting (FACS) were prepared and analyzed as described previously (![]()
35S-methionine incorporation:
Strains were grown to log phase in SD-complete medium and diluted to an OD600 of 0.05 in 4.5 ml of fresh prewarmed SD-complete medium; 1 ml was removed to determine the starting OD600 and, to the remaining 3.5 ml, 35S-methionine was added (in 100 µl SD-complete medium) to a final concentration of 10 µM (the concentration of cold methionine in SD-complete medium is 130 µM). The zero timepoint was taken immediately and the cultures were incubated at 37°. During the incubation, samples were taken at several timepoints. For each timepoint, 300 µl aliquots were taken and added directly to 700 µl of 10% trichloroacetic acid (TCA) on ice. A 20 µl aliquot was added directly to a glass fiber filter to act as a control for the total number of counts available in each labeling reaction. At the end of the experiment, the samples were heated at 95° for 4 min to deacylate tRNAs and were then filtered through TCA-soaked glass fiber filters, which were washed twice with ice-cold 10% TCA and once with acetone. The filters were then counted by liquid scintillation. Values for each strain were calculated by dividing the number of counts (1) by the starting OD600 of the culture and (2) by the counts obtained from the control filters. Values were then plotted as normalized against a wild-type control strain.
Morphological observations:
Cells were stained with rhodamine phalloidin (stain for actin filaments) and 4',6'-diamidino-2-phenylindole (DAPI) (stain for DNA) as described (![]()
![]()
Multicopy suppressor isolation:
Strains SH121 (class A) and SH229 (class B) were used to isolate high-copy suppressors of unique and shared function defects, respectively. Class D mutant SH129 (tor2-29 ts) grows slower at nonpermissive temperature than class D mutant SH130 (tor2-30 ts), indicating that the unique function encoded by tor2-29 ts is not completely intact, but still sufficient for growth. We did not use class B mutants SH230 or SH2119 to isolate suppressors because they had high reversion rates. The isolation of the multicopy suppressors was performed using a 2µ based library derived from strain R1 (![]()
| RESULTS |
|---|
Isolation of temperature sensitive tor2 mutants:
A strain disrupted in TOR2 arrests after three to four generations with no previously observed cell cycle phenotype. In contrast, strains disrupted in TOR1 and TOR2 arrest rapidly, within one cell cycle, and in early G1 (![]()
![]()
![]()
![]()
To define further the two functions of TOR2, we attempted to isolate temperature-sensitive tor2 mutants that were defective for only one of the two TOR2 functions. We isolated 29 independent plasmid-borne tor2ts alleles using a screen based on in vitro mutagenesis and plasmid shuffling (see MATERIALS AND METHODS; ![]()
The growth of the TOR1 tor2ts strains (SH1x series) and tor1 tor2ts strains (SH2x series) at 24° and 37° on solid rich medium containing glucose as the carbon source (YPD) was assessed. Table 2 summarizes these results, from which we have classified the mutant strains into four classes, A through D, based on whether a mutant was defective for the unique, the shared, or both functions of TOR2 (Table 3). Class A mutants, represented by strains SH121 (tor2-21ts) and SH1156 (tor2-156ts), did not form colonies after 3 days at 37° and were thus temperature sensitive for the TOR2-unique function (Figure 1). The shared function is provided in these mutants by the chromosomal wild-type TOR1 gene. Interestingly, we never obtained a class A mutant in which the shared function is provided by TOR2, i.e., a TOR2 allele that is defective only for the unique function. Class B mutants, represented by strains SH230 (tor1 tor2-30 ts) and SH2119 (tor1 tor2-119 ts), also arrested growth at 37° and were temperature sensitive only for the shared function (see class D below). Class C mutants, represented by strains SH221 (tor1 tor2-21ts) and SH2156 (tor1 tor2-156ts), were temperature sensitive for both TOR2 functions. Class D consists of pseudomutants and is represented by strains SH130 (tor2-30 ts) and SH1119 (tor2-119 ts). These pseudomutants formed normal-sized colonies at all temperatures on solid medium, indicating that the class B mutants, which contain the same TOR2 alleles but in a tor1 background, were defective only in the shared function. Some class D mutants had a partial growth defect indicating that, in these strains, the TOR2-unique function was partly defective.
|
|
|
Suppression of growth defects by nutrient source or medium supplements:
Because the TORs have previously been implicated in nutrient sensing (![]()
![]()
|
Growth at 37° was also assessed on YPD medium supplemented with 1 M sorbitol, 0.5 M NaCl or 0.1 M CaCl2. The growth defect of Class A mutants was fully suppressed by 1 M sorbitol or 0.5 M NaCl, and was partly suppressed by 0.1 M CaCl2. Allele-specific effects were seen for class B mutants grown on medium containing one of the three supplements, ranging from complete suppression to no suppression (Table 4). The growth defect of class C mutants was not suppressed by 1 M sorbitol, 0.5 M NaCl, or 0.1 M CaCl2. Class D slow-growing mutants all grew like wild type on medium supplemented with 1 M sorbitol, 0.5 M NaCl, or 0.1 M CaCl2, with the exception of SH1152 (TOR1 tor2-152ts), for which CaCl2 had no effect. Thus, of all the mutants, class A mutants were most susceptible to suppression by either the carbon source or media supplements.
Class A mutants arrest in G2/M, and class B and C mutants arrest in G1:
We characterized further the growth and cell cycle phenotypes of the class A, B, and C mutants. The growth and cell cycle arrests of the mutants were analyzed by determining growth curves (OD600) and by FACS analysis. Class A mutants SH121 (tor2-21ts) and SH1156 (tor2-156ts) ceased to grow after 78 hr at 37°, after having completed two to three divisions (Figure 3 and data not shown). Most of the arrested cells (>80%) contained a 2n DNA content, indicating a block in the G2/M phase of the replicative cycle (Figure 2 and data not shown). Scoring the cells morphologically for cell cycle distribution showed that these strains arrested with an increased number of cells in different stages of budding, as described in greater detail below (Table 5 and data not shown). This postreplicative budded-cell arrest upon shifting a tor2ts mutant to nonpermissive temperature differs from an apparently random arrest that was observed when TOR2 was depleted by down-regulating its transcription using the regulatable GAL1 promoter (![]()
![]()
|
|
|
In contrast to class A mutants, all the class B and C mutants arrested within one generation (within 34 hr) with >80% of the cells in G1 (1n DNA content). Results are shown for the class B mutant SH230 (tor1 tor2-30 ts) and the class C mutant SH221 (tor1 tor2-21ts) (Figure 2; Figure 3). In addition, the average cell size of the strains increased after shift to 37°, for unknown reasons. The G1 arrest is in agreement with previous observations (![]()
![]()
![]()
The class D mutants SH130 (tor2-30 ts) and SH1119 (tor2-119 ts) formed normal-sized colonies on solid medium. In liquid medium, strain SH130 exhibited a slight reduction in growth rate, as compared to the control strain, but this pseudomutant eventually reached a stationary phase cell density similar to that of control strain SH100.
The unique function of TOR2 is involved in the organization of the actin cytoskeleton:
We have shown recently that the unique function of TOR2 is required for the organization of the actin cytoskeleton. Class A strain SH121 is defective in the cell-cycle-dependent, polarized distribution of the actin cytoskeleton, and overexpression of the actin- and tubulin-specific chaperone TCP20 suppresses both the growth and actin defects of SH121 (tor2-21ts) (![]()
|
The budded cells in this analysis were assessed for actin distribution (Table 5; Figure 4). Actin was considered to be abnormally distributed (apolar) if more than five actin patches could still be seen in the mother cell and if these patches were not adjacent to the bud neck. Class A mutant SH121 (tor2-21ts) exhibited poor polarization of actin patches, with 80% of the cells analyzed having improperly distributed actin (Figure 4). Additionally, very few or no actin cables could be seen in the mutant cells, implying defects in cable assembly. The other class A mutant SH1156 (tor2-156ts) exhibited a similar defect in actin distribution (data not shown). Interestingly, 47% of the class D mutant (SH130) cells had an altered actin distribution as compared with 16% of the control cells (SH100). This intermediate effect was apparently not sufficient to severely affect growth, since SH130 (tor2-30 ts) formed normal colonies. Yeast cells can tolerate a certain amount of cytoskeletal perturbation and still grow relatively normally, as observed previously with mutants defective in actin itself or in actin-binding proteins (![]()
The shared function of TOR2 is involved in protein synthesis:
We have recently demonstrated that depletion of TOR1 and TOR2 or rapamycin treatment of wild-type cells causes an immediate and severe block in protein synthesis. Furthermore, we have shown that this block occurs at the level of translation initiation and is the cause of the early G1 arrest seen with the loss of TOR or rapamycin treatment (![]()
|
Overexpression of MSS4, PKC1, PLC1, RHO2, ROM2, or SUR1 rescues a class A mutant:
The above analysis of class A, class B, and class C mutants supports the existence of at least two functions for TOR2 (Table 3). Class A mutants arrest within a few generations as small-budded cells in G2/M and with an actin defect, whereas class B and C mutants arrest within one generation in G1 because of a translation initiation defect. To identify the two pathways by which TOR2 may control actin organization and translation initiation, we isolated multicopy suppressors of class A mutant SH121 and of class B mutant SH229 (see MATERIALS AND METHODS).
To identify the pathway mediating the TOR2-unique function, we isolated high-copy suppressors that rescue class A mutant SH121 (tor2-21ts). Plasmids isolated as multicopy suppressors were sequenced and subcloned to identify the ORF with suppressor activity. TOR2 itself was isolated as a suppressor four times. Other multicopy suppressors were MSS4, PKC1, PLC1, RHO2, and SUR1 (Figure 6; Table 6).
|
|
MSS4, a strong suppressor obtained once (clone pSH121.10), encodes an essential PI-4-P 5-kinase homolog (![]()
![]()
![]()
![]()
PKC1, a strong suppressor obtained twice (clones pSH121.8 and pSH121.25), encodes the yeast homolog of protein kinase C (![]()
PLC1, a moderate suppressor obtained once (clone pSH121.56), encodes the yeast homolog of phospholipase C (![]()
![]()
![]()
RHO2, a strong suppressor obtained once (clone pSH121.33), encodes a small Rho-like GTPase. We also found RHO2 as a multicopy suppressor of a tor2 mutation by an independent and concurrent approach (![]()
SUR1, a weak suppressor obtained three times (clones pSH121.28, pSH121.30, and pSH121.59), encodes a protein with no homology to known proteins. The function of SUR1 is unknown, but it is possibly involved in the maintenance of phospholipid levels (see DISCUSSION).
Overexpression of PLC1 or MSS4 rescues a class B mutant:
To identify the pathway mediating the TOR-shared function, we isolated multicopy suppressors that rescue class B mutant SH229 (tor1 tor2-29 ts). TOR2 itself was isolated as a multicopy suppressor 12 times. Five other suppressor plasmids were obtained and found to have overlapping fragments containing the PLC1 gene in common. We confirmed that overexpression of PLC1 alone was sufficient for suppression by transforming the class B mutants SH229 (tor1 tor2-29 ts) and SH2103 (tor1 tor2-103ts) with pSH25 (pSEY18::PLC1) and assessing growth on rich medium at the nonpermissive temperature (Figure 6 and data not shown). The suppression by PLC1 was moderate.
We then examined whether any of the multicopy suppressors, other than PLC1, that rescued a class A mutant could also rescue a class B mutant (Figure 6B; Table 6). Neither PKC1, RHO2, ROM2, nor SUR1 could rescue class B mutant SH229, as judged by growth on solid rich medium at 37°, even after prolonged incubation. MSS4 was able to rescue strain SH229 at high temperature; however, the suppression by MSS4 was weaker than that by PLC1 and evident only after prolonged incubation.
As PLC1 was isolated as a multicopy supppressor of a TOR-shared function defect, we also examined whether high-copy PLC1 could suppress a tor1 mutation. tor1 strains have a slow-growth phenotype that is exacerbated at low and high temperatures, and at least at 39° tor1 cells accumulate in the G1 phase of the cell cycle (S. B. HELLIWELL and M. N. HALL, unpublished results). We transformed plasmids bearing TOR1, PLC1, and an empty vector into MH349-3d (tor1::LEU2-4) and examined the growth of the resulting transformants at 24° and 39°. At both temperatures, multicopy PLC1 was able to partially suppress the growth defect of the tor1 strain (data not shown), confirming that overexpression of PLC1 could suppress a defect in the TOR-shared function. As PLC1 was able to suppress defects in either the shared or the unique function of TOR2, we examined whether it could rescue a class C mutant that lacks all TOR function. pSH25 (pSEY18::PLC1) was transformed into class C mutant SH221 (tor1 tor2-21ts ) and assessed for growth at the nonpermissive temperature. After 2.5 days incubation at 37°, transformants formed small colonies, indicating that overexpression of PLC1 could weakly suppress a complete TOR deficiency (Figure 6C). Overexpression of MSS4, PKC1, RHO2, ROM2, or SUR1 did not rescue strain SH221.
| DISCUSSION |
|---|
TOR1 and TOR2 encode 67% identical PI kinase homologs, and mutations in either gene confer rapamycin resistance (![]()
![]()
![]()
![]()
![]()
![]()
Twenty-nine tor2ts alleles were obtained and characterized. All of the tor2ts alleles were defective in the TOR-shared function such that all tor1 tor2ts strains arrested growth like strains depleted for TOR. However, the same alleles varied in their ability to provide the TOR2-unique function such that they caused growth defects of varying severity when in a strain background containing a wild-type TOR1 gene. The alleles varied from being unaffected (tor2-30 ts and tor2-119 ts) to being fully defective for the unique function (tor2-21ts and tor2-156ts). No TOR2 allele was isolated that was temperature sensitive for only the unique function, for unknown reasons.
The alleles obtained allowed the construction of three classes of tor mutants that arrest growth for different reasons. Class A mutants, strains SH121 (tor2-21ts) and SH1156 (tor2-156ts), are tor2-unique ts and arrest within a few generations, primarily as small-budded cells with a 2n DNA content. These mutants are defective in the organization of the actin cytoskeleton. The actin defect is presumably the cause of growth arrest (![]()
Suppressor analyses with the mutants deficient in either the shared function or the unique function provided insight into the nature of the possible signaling events downstream of TOR2. Many genes were isolated that when overexpressed allow growth of a tor2ts strain lacking the TOR2-unique function. These genes encode proteins (MSS4, PKC1, PLC1, RHO2, ROM2, and SUR1) directly or indirectly implicated in signaling and, in particular, in protein kinase C signaling. MSS4 is a PI-4-P 5-kinase homolog (![]()
, which has been shown to exhibit a calcium dependence with respect to its hydrolytic activity toward PI and PI-4,5-P2 (PIP2) (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Furthermore, we anticipate that at least some of the suppressors, including PKC1, are in a TOR2 pathway. First, the growth arrest phenotype of the class A mutant SH121 (tor2-21ts) is similar to the arrest phenotype of strains expressing a conditional allele of PKC1; both tor2-21ts and pkc1ts mutants arrest with increased numbers of small-budded cells containing replicated DNA, and both mutants are rescued by the addition of 0.1 M CaCl2, 0.5 M NaCl, or the osmotic stabilizer sorbitol to the growth medium (![]()
![]()
![]()
![]()
![]()
![]()
A surprising observation was that two of the multicopy suppressors, MSS4 and PLC1, rescue both class A and class B mutants. Regardless of whether MSS4 and PLC1 are in a TOR2 pathway or in a parallel pathway, this finding suggests that the two signaling functions of TOR2 are more related than previously thought. It remains to be determined how the two different readouts of TOR2translation initiation and organization of the actin cytoskeletonare affected by the same signaling proteins. There may be crosstalk between two TOR2 signaling pathways such that overexpressing a protein in one pathway affects the other. Alternatively, two pathways may have common components or the common suppressors may have two functions. A sharing of components between two TOR2 signaling pathways could ensure that temporal (protein synthesis) and spatial (actin cytoskeleton organization) control of cell growth are coordinated (![]()
| FOOTNOTES |
|---|
1 Present address: Institute for Biochemistry and Molecular Biology, University of Bern, CH-3012 Bern, Switzerland. ![]()
| ACKNOWLEDGMENTS |
|---|
We thank THOMAS BECK, GERHARD PARAVICINI, JEREMY THORNER and SCOTT EMR for plasmids, ANJA SCHMIDT and TOBIAS SCHMELZLE for comments on the manuscript, and members of the lab for helpful discussions. N. B. was the recipient of a long-term European Molecular Biology Organization fellowship. This work was supported by grants from the Swiss National Science Foundation and the Canton of Basel to M.N.H.
Manuscript received June 13, 1997; Accepted for publication October 6, 1997.
| LITERATURE CITED |
|---|
BARBET, N., U. SCHNEIDER, S. B. HELLIWELL, I. STANSFIELD, and M. TUITE et al., 1996 TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 7:25-42[Abstract].
BAUER, F., M. URDACI, M. AIGLE, and M. CROUZET, 1993 Alteration of a yeast SH3 protein leads to conditional viability with defects in cytoskeletal and budding patterns. Mol. Cell. Biol. 13:5070-5084
BERETTA, L., A.-C. GINGRAS, Y. V. SVITKIN, M. N. HALL, and N. SONENBERG, 1996 Rapamycin blocks the phosphorylatin of 4E--BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15:658-664[Medline].
BROWN, E. J., M. W. ALBERS, T. B. SHIN, K. ICHIKAWA, and C. T. KEITH et al., 1994 A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369:756-758[Medline].
BROWN, E. J., P. A. BEAL, C. T. KEITH, J. CHEN, and T. B. SHIN et al., 1995 Control of p70 S6 kinase by kinase activity of FRAP in vivo.. Nature 377:441-446[Medline].
CAFFERKEY, R., P. R. YOUNG, M. M. MCLAUGHLIN, D. J. BERGSMA, and Y. KOLTIN et al., 1993 Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol. Cell. Biol. 13:6012-6023
CHIU, M. I., H. KATZ, and V. BERLIN, 1994 RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc. Natl. Acad. Sci. USA 91:12574-12578
CROUZET, M., M. URDACI, L. DULAU, and M. AIGLE, 1991 Yeast mutant affected for viability upon nutrient starvation: characterization and cloning of the RVS161 gene. Yeast 7:727-743[Medline].
DESFARGES, L., P. DURRENS, H. JUGUELIN, C. CASSAGNE, and M. BONNEU et al., 1993 Yeast mutants affected in viability upon starvation have a modified phospholipid composition. Yeast 9:267-277[Medline].
DI COMO, C. and K. ARNDT, 1996 Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev. 10:1904-1916[Abstract].
FLICK, J. S. and J. THORNER, 1993 Genetic and biochemical characterization of a phosphatidylinositol-specific phospholipase C in Saccharomyces cerevisiae.. Mol. Cell. Biol. 13:5861-5876
HEITMAN, J., N. R. MOVVA, and M. N. HALL, 1991 Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253:905-909
HELLIWELL, S. B., P. WAGNER, J. KUNZ, M. DEUTER-REINHARD, and R. HENRIQUEZ et al., 1994 TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol. Biol. Cell. 5:105-118[Abstract].
IGUAL, J. C., A. L. JOHNSON, and L. H. JOHNSTON, 1996 Coordinated regulation of gene expression by the cell cycle transcription factor SWI4 and the protein kinase C MAP kinase pathway for yeast cell integrity. EMBO J. 15:5001-5013[Medline].
KAMADA, Y., H. QADOTA, C. PYTHON, Y. ANRAKU, and Y. OHYA et al., 1996 Activation of yeast protein kinase C by Rho1 GTPase. J. Biol. Chem. 271:9193-9196
KUNZ, J., R. HENRIQUEZ, U. SCHNEIDER, M. DEUTER-REINHARD, and N. R. MOVVA et al., 1993 Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73:585-596[Medline].
LEVIN, D. E. and E. BARTLETT-HEUBUSCH, 1992 Mutants in the S. cerevisiae PKC1 gene display a cell cyclespecific osmotic stability defect. J. Cell Biol. 116:1221-1229
LEVIN, D. E., F. O. FIELDS, R. KUNISAWA, J. M. BISHOP, and J. THORNER, 1990 A candidate protein kinase C gene, PKC1, is required for the S. cerevisiae cell cycle. Cell 62:213-224[Medline].
MAZZONI, C., P. ZAROV, A. RAMBOURG, and C. MANN, 1993 The SLT2 (MPK1) MAP kinase homolog is involved in polarized cell growth in Saccharomyces cerevisiae.. J. Cell Biol. 123:1821-1833
NONAKA, H., K. TANAKA, H. HIRANO, T. FUJIWARA, and H. KOHNO et al., 1995 A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog of protein kinase C, which leads to activation of the MAP kinase cascade in Saccharomyces cerevisiae.. EMBO J. 14:5931-5938[Medline].
NOVICK, P. and D. BOTSTEIN, 1985 Phenotypic analysis of temperature-sensitive yeast actin mutants. Cell 40:405-416[Medline].
OZAKI, K., K. TANAKA, H. IMAMURA, T. HIHARA, and T. KAMEYAMA et al., 1996 Rom1p and Rom2p are GDP/GTP exchange proteins (GEPs) for the Rho1p small GTP binding protein in Saccharomyces cerevisiae.. EMBO J. 15:2196-2207[Medline].
PAYNE, W. E. and M. FITZGERALD-HAYES, 1993 A mutation in PLC1, a candidate phosphoinositide-specific phospholipase C gene from Saccharomyces cerevisiae, causes aberrant mitotic chromosome segregation. Mol. Cell. Biol. 13:4351-4364
PRINGLE, J. R., A. E. PRESTON, A. E. M. ADAMS, T. STEARNS, and D. G. DRUBIN, 1989 Fluorescence microscopy methods for yeast. Methods Cell. Biol. 31:357-435[Medline].
SABATINI, D. M., H. ERDJUMENT-BROMAGE, M. LUI, P. TEMPST, and S. H. SNYDER, 1994 RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78:35-43[Medline].
SABERS, C. J., M. M. MARTIN, G. J. BRUNN, J. M. WILLIAMS, and F. J. DUMONT et al., 1995 Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 270:815-822
SCHMIDT, A., J. KUNZ, and M. N. HALL, 1996 TOR2 is required for the organization of the actin cytoskeleton in yeast. Proc. Natl. Acad. Sci. USA 93:13780-13785
SCHMIDT, A., M. BICKLE, T. BECK, and M. N. HALL, 1997 The yeast phosphatidylinositol kinase homologue TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 88:531-542[Medline].
SHERMAN, F., 1991 Getting started with yeast, pp. 320 in Guide to Yeast Genetics and Molecular Biology, edited by C. GUTHRIE and J. FINK. Cold Spring Harbor Press, Cold Spring Harbor, NY.
SIKORSKI, R. S., and J. D. BOEKE, 1991 In vitro mutagenesis and plasmid shuffling: from cloned gene to mutant yeast, pp. 302318 in Guide to Yeast Genetics and Molecular Biology, edited by C. GUTHRIE and G. FINK. Cold Spring Harbor Press, Cold Spring Harbor, NY.
TAKITA, Y., Y. OHYA, and Y. ANRAKU, 1995 The CLS2 gene encodes a protein with multiple membrane-spanning domains that is important Ca2+ tolerance in yeast. Mol. Gen. Genet. 246:269-281[Medline].
THOMAS, G. and M. N. HALL, 1997 TOR signalling and control of cell growth. Curr. Opin. Cell Biol. 9:782-787[Medline].
VANDENBOL, M., J.-C. JAUNIAUX, S. VISSERS, and M. GRENSON, 1987 Isolation of the NPR1 gene responsible for the reactivation of ammonia-sensitive amino-acid permeases in Saccharomyces cerevisiae.. Eur. J. Biochem. 164:607-612[Abstract].
YAMAMOTO, A., D. B. DEWALD, I. V. BORONENKOV, R. A. ANDERSON, and S. D. EMR et al., 1995 Novel PI(4)P 5-kinase homologue, Fab1p, essential for normal vacuole function and morphology in yeast. Mol. Biol. Cell. 6:525-539[Abstract].
YOKO-O, T., Y. MATSUI, H. YAGISAWA, H. NOJIMA, and I. UNO et al., 1993 The putative phosphoinositide-specific phospholipase C gene, PLC1, of the yeast Saccharomyces cerevisiae is important for cell growth. Proc. Natl. Acad. Sci. USA 90:1804-1808
YOSHIDA, S., Y. OHYA, M. GOEBL, A. NAKANO, and Y. ANRAKU, 1994a A novel gene, STT4, encodes a phosphotidylinositol 4-kinase in the PKC1 protein kinase pathway of Saccharomyces cerevisiae.. J. Biol. Chem. 269:1166-1172
YOSHIDA, S., Y. OHYA, A. NAKANO, and Y. ANRAKU, 1994b Genetic interactions among genes involved in the STT4-PKC1 pathway of Saccharomyces cerevisiae.. Mol. Gen. Genet. 242:631-640[Medline].
ZHENG, X. F., D. FLORENTINO, J. CHEN, G. R. CRABTREE, and S. L. SCHREIBER, 1995 TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82:121-130[Medline].
This article has been cited by other articles:
![]() |
H.-L. Ho, H.-Y. Lee, H.-C. Liao, and M.-Y. Chen Involvement of Saccharomyces cerevisiae Avo3p/Tsc11p in Maintaining TOR Complex 2 Integrity and Coupling to Downstream Signaling Eukaryot. Cell, August 1, 2008; 7(8): 1328 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huttenhower and O.G. Troyanskaya Assessing the functional structure of genomic data Bioinformatics, July 1, 2008; 24(13): i330 - i338. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aronova, K. Wedaman, S. Anderson, J. Yates III, and T. Powers Probing the Membrane Environment of the TOR Kinases Reveals Functional Interactions between TORC1, Actin, and Membrane Trafficking in Saccharomyces cerevisiae Mol. Biol. Cell, August 1, 2007; 18(8): 2779 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
|










